Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

SIMPLE SUMMARY: Food and Drug Administration (FDA) drug approvals from July 2007 to June 2019 were reviewed to identify oncology approvals, and trials with age details were reviewed for the study. We hypothesized that the clinical trials that do not report race are likely to suffer from a higher deg...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayakrishnan, Thejus, Aulakh, Sonikpreet, Baksh, Mizba, Nguyen, Kianna, Ailawadhi, Meghna, Samreen, Ayesha, Parrondo, Ricardo, Sher, Taimur, Roy, Vivek, Manochakian, Rami, Paulus, Aneel, Chanan-Khan, Asher, Ailawadhi, Sikander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616211/
https://www.ncbi.nlm.nih.gov/pubmed/34830924
http://dx.doi.org/10.3390/cancers13225770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616211/
https://www.ncbi.nlm.nih.gov/pubmed/34830924
http://dx.doi.org/10.3390/cancers13225770

Ejemplares similares